INCONTESTABLE® Blog
April 19, 2024
Webinar
Advertising Self-Regulation in 2024: Q&A with NAD Vice President Laura Brett
January 30, 2024
Never miss an Insight.
Sign upEvent
Drafting Effective Pharmaceutical Patents Training Course Drafting Effective Pharmaceutical Patents Training Course
May 13-16, 2024
Virtual
Event
2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities 2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities
March 20, 2024
Boston
Event
2024 ACC SFBA Life Sciences Conference 2024 ACC SFBA Life Sciences Conference
March 19-21, 2024
Brisbane
Event
Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation
February 15, 2024
Webinar
Event
Navigating Your Life Sciences Opposition: Tips for Best Practice When You Are Opposing or Opposed Navigating Your Life Sciences Opposition: Tips for Best Practice When You Are Opposing or Opposed
December 12, 2023
Webinar
Event
Biosimilars and Interchangeable Biologics: New FDA Draft Guidance Clarifying Application Process for Approval Biosimilars and Interchangeable Biologics: New FDA Draft Guidance Clarifying Application Process for Approval
November 28, 2023
Webinar
Event
3rd Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA 3rd Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA
October 10-26, 2023
Virtual
Event
Protecting Your Life Sciences Innovations: Challenges in the USA and Europe Protecting Your Life Sciences Innovations: Challenges in the USA and Europe
July 27, 2023
Taipei
Articles
Intellectual Property Strategies for Developing Biofuels Intellectual Property Strategies for Developing Biofuels
July 24, 2023
Chemical Industry JournalDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.